187 related articles for article (PubMed ID: 31785531)
1. HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling.
Zhou Y; Wang K; Zhou Y; Li T; Yang M; Wang R; Chen Y; Cao M; Hu R
Redox Biol; 2020 Jan; 29():101390. PubMed ID: 31785531
[TBL] [Abstract][Full Text] [Related]
2. HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy.
Liu T; Fang Y; Zhang H; Deng M; Gao B; Niu N; Yu J; Lee S; Kim J; Qin B; Xie F; Evans D; Wang L; Lou W; Lou Z
Cancer Res; 2016 Feb; 76(3):572-81. PubMed ID: 26676747
[TBL] [Abstract][Full Text] [Related]
3. dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer.
Hu Q; Qin Y; Xiang J; Liu W; Xu W; Sun Q; Ji S; Liu J; Zhang Z; Ni Q; Xu J; Yu X; Zhang B
Cell Prolif; 2018 Aug; 51(4):e12456. PubMed ID: 29701272
[TBL] [Abstract][Full Text] [Related]
4. CPT1B maintains redox homeostasis and inhibits ferroptosis to induce gemcitabine resistance via the KEAP1/NRF2 axis in pancreatic cancer.
Tuerhong A; Xu J; Wang W; Shi S; Meng Q; Hua J; Liu J; Zhang B; Yu X; Liang C
Surgery; 2024 May; 175(5):1264-1275. PubMed ID: 38302326
[TBL] [Abstract][Full Text] [Related]
5. aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1.
Tian L; Lu Y; Yang T; Deng Z; Xu L; Yao W; Ma C; Li X; Zhang J; Liu Y; Wang J
Redox Biol; 2019 Apr; 22():101149. PubMed ID: 30822690
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy.
Lister A; Nedjadi T; Kitteringham NR; Campbell F; Costello E; Lloyd B; Copple IM; Williams S; Owen A; Neoptolemos JP; Goldring CE; Park BK
Mol Cancer; 2011 Apr; 10():37. PubMed ID: 21489257
[TBL] [Abstract][Full Text] [Related]
7. [Overexpression of Keap1 inhibits the cell proliferation and metastasis and overcomes the drug resistance in human lung cancer A549 cells].
Weng X; Yan YY; Tong YH; Fan Y; Zeng JM; Wang LL; Lin NM
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):404-10. PubMed ID: 27346396
[TBL] [Abstract][Full Text] [Related]
8. P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex.
Garufi A; Giorno E; Gilardini Montani MS; Pistritto G; Crispini A; Cirone M; D'Orazi G
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33669070
[TBL] [Abstract][Full Text] [Related]
9. FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway.
Zhou Y; Chen Y; Shi Y; Wu L; Tan Y; Li T; Chen Y; Xia J; Hu R
J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36719368
[TBL] [Abstract][Full Text] [Related]
10. p62 promotes proliferation, apoptosis‑resistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis.
Jiang G; Liang X; Huang Y; Lan Z; Zhang Z; Su Z; Fang Z; Lai Y; Yao W; Liu T; Hu L; Wang F; Huang H; Liu L; Jiang X
Oncol Rep; 2020 May; 43(5):1547-1557. PubMed ID: 32323805
[TBL] [Abstract][Full Text] [Related]
11. CASC9 potentiates gemcitabine resistance in pancreatic cancer by reciprocally activating NRF2 and the NF-κB signaling pathway.
Zhang Z; Chen L; Zhao C; Gong Q; Tang Z; Li H; Tao J
Cell Biol Toxicol; 2023 Aug; 39(4):1549-1560. PubMed ID: 35913601
[TBL] [Abstract][Full Text] [Related]
12. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant.
Kageyama S; Saito T; Obata M; Koide RH; Ichimura Y; Komatsu M
Mol Cell Biol; 2018 Apr; 38(7):. PubMed ID: 29339380
[TBL] [Abstract][Full Text] [Related]
13. Nucleolar HEAT Repeat Containing 1 Up-regulated by the Mechanistic Target of Rapamycin Complex 1 Signaling Promotes Hepatocellular Carcinoma Growth by Dominating Ribosome Biogenesis and Proteome Homeostasis.
Yang XM; Wang XQ; Hu LP; Feng MX; Zhou YQ; Li DX; Li J; Miao XC; Zhang YL; Yao LL; Nie HZ; Huang S; Xia Q; Zhang XL; Jiang SH; Zhang ZG
Gastroenterology; 2023 Sep; 165(3):629-646. PubMed ID: 37247644
[TBL] [Abstract][Full Text] [Related]
14. MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.
Zhang B; Xu J; Li C; Shi S; Ji S; Xu W; Liu J; Jin K; Liang D; Liang C; Liu L; Liu C; Qin Y; Yu X
Curr Mol Med; 2016; 16(4):404-11. PubMed ID: 26980696
[TBL] [Abstract][Full Text] [Related]
15. KEAP1/NRF2 axis regulates H
He J; Zhang X; Lian C; Wu J; Fang Y; Ye X
Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Factor Erythroid 2-Related Factor 2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression.
Matsumoto R; Hamada S; Tanaka Y; Taguchi K; Yamamoto M; Masamune A
J Pharmacol Exp Ther; 2021 Oct; 379(1):33-40. PubMed ID: 34321315
[TBL] [Abstract][Full Text] [Related]
17. p62 promotes bladder cancer cell growth by activating KEAP1/NRF2-dependent antioxidative response.
Li T; Jiang D; Wu K
Cancer Sci; 2020 Apr; 111(4):1156-1164. PubMed ID: 31967368
[TBL] [Abstract][Full Text] [Related]
18. Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway.
Xiang Y; Ye W; Huang C; Yu D; Chen H; Deng T; Zhang F; Lou B; Zhang J; Shi K; Chen B; Zhou M
Oxid Med Cell Longev; 2018; 2018():2360427. PubMed ID: 29849873
[TBL] [Abstract][Full Text] [Related]
19. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
[TBL] [Abstract][Full Text] [Related]
20. GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma.
Hayashi M; Guida E; Inokawa Y; Goldberg R; Reis LO; Ooki A; Pilli M; Sadhukhan P; Woo J; Choi W; Izumchenko E; Gonzalez LM; Marchionni L; Zhavoronkov A; Brait M; Bivalacqua T; Baras A; Netto GJ; Koch W; Singh A; Hoque MO
Sci Signal; 2020 Aug; 13(645):. PubMed ID: 32817372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
